Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „OATP1B1“
Suchtreffer
Begriffe & Kennungen
Ifirmasta (previously Irbesartan Krka) · 4.5 · Repaglinide: Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIqirvo · 4.5 · CYP3A, Breast Cancer Resistance Protein (BCRP), organic anion transporting polypeptides 1B1 (OATP1B1) and OATP
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Hydrochlorothiazide Zentiva (previously Irbesartan Hydrochlorothiazide Winthrop) · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIrbesartan Teva · 4.5 · 5 Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbes
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan Zentiva (previously Irbesartan Winthrop) · 4.5 · Repaglinide: irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesa
Eintrag öffnenIrbesartan/Hydrochlorothiazide Teva · 4.5 · Repaglinide Irbesartan has the potential to inhibit OATP1B1. In a clinical study, it was reported that irbesar
Eintrag öffnenIsturisa · 4.5 · In vitro data for osilodrostat and its major metabolite M34.5 suggest an inhibitory potential for OATP1B1, OCT
Eintrag öffnenJardiance · 4.5 · An interaction study with gemfibrozil, an in vitro inhibitor of OAT3 and OATP1B1/1B3 transporters, showed that
Eintrag öffnenJardiance · 4.5 · Empagliflozin does not inhibit human uptake transporters such as OAT3, OATP1B1, and OATP1B3 in vitro at clinic
Eintrag öffnenJardiance · 4.5 · Inhibition of OATP1B1/1B3 transporters by co-administration with rifampicin resulted in a 75% increase in Cmax
Eintrag öffnenJevtana · 4.5 · OATP1B1 In vitro, cabazitaxel has also been shown to inhibit the transport proteins of the Organic Anion Trans
Eintrag öffnenJinarc · 4.5 · OATP1B1/OAT3/BCRP and OCT1: In-vitro studies indicate that tolvaptan or its oxobutyric metabolite may have the
Eintrag öffnenJoenja · 4.5 · OATP1B1, OATP1B3, and BCRP substrates When co-administered, leniolisib increased rosuvastatin exposure 2-fold.
Eintrag öffnenKaftrio · 4.5 · 9 In vitro studies showed that TEZ is a substrate for the uptake transporter OATP1B1 and efflux transporters P
Eintrag öffnenKaftrio · 4.5 · ELX and M23-ELX inhibit uptake by OATP1B1 and OATP1B3 in vitro. TEZ/IVA increased the AUC of pitavastatin, an
Eintrag öffnenKaftrio · 4.5 · ELX and M23-ELX inhibit uptake by OATP1B1 and OATP1B3 in vitro. TEZ/IVA increased the AUC of pitavastatin, an
Eintrag öffnen